FLNA — FILANA THERAPEUTICS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1069530 ·
Last close
$0.93
Market Cap
$44.93M
52W High
$1.60
52W Low
$0.85
ADV30
317,658
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -9,393,000 | -8,603,000 | 103,903,000 | 82,681,000 | 40,294,000 |
| Mar 2026 | 0 | — | -11,168,000 | -10,331,000 | 108,367,000 | 86,573,000 | 40,226,000 |
| Dec 2025 | 0 | — | -14,288,000 | -12,539,000 | 118,355,000 | 95,502,000 | 43,952,000 |
| Sep 2025 | 0 | — | -11,860,000 | -10,807,000 | 129,733,000 | 106,080,000 | 48,165,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-28,702,000
Investing CF
$-581,000
Financing CF
$-396,000
CapEx
$-558,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.87
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-515,018,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-46,709,000
Pretax Income TTM
$-42,280,000
Interest Exp TTM
—
Analysts
2
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -96,126,000 | -90,973,000 | 118,355,000 | 43,952,000 | — | -32,252,000 |
| Dec 2024 | 0 | -142,279,000 | -24,342,000 | 157,533,000 | 11,829,000 | — | -116,929,000 |
| Dec 2023 | 0 | -107,333,000 | -97,217,000 | 151,663,000 | 14,195,000 | — | -82,025,000 |
| Dec 2022 | 0 | -81,482,000 | -76,246,000 | 234,834,000 | 7,295,000 | — | -77,514,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-31,017,000
OpCashFlow TTM
$0
Assets (Latest)
$234,834,000
Forward EPS
—
Max Pain — expiry 2027-01-15
max pain strike: $1.00 · spot: $0.93 · call oi: 1,986 · put oi: 747
Expected Move to 2027-01-15:
±$0.49
(53.29%) —
implied range
$0.43 –
$1.42
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VERU | VERU INC. | $44.16M | $2.59 | — |
| GRCE | Grace Therapeutics, Inc. | $45.86M | $2.18 | — |
| MREO | Mereo BioPharma Group plc | $46.23M | $0.29 | — |
| BHST | BIOHARVEST SCIENCES INC. | $46.47M | $2.05 | — |
| IXHL | Incannex Healthcare Inc. | $43.31M | $3.62 | — |
News headlines (Yahoo Finance, 1h cache)
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
2026-07-29 12:00 · Yahoo
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
2026-05-07 12:00 · Yahoo
Data I/O And 2 Other Promising Penny Stocks To Watch
2026-05-29 18:05 · Yahoo
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
2026-05-05 12:00 · Yahoo
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
2026-04-15 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.